Skip to main content

Nonprofit · EIN 52-1782065

NATIONAL BREAST CANCER COALITION FUND

Also known as BREAST CANCER COALITION

Tax-exempt · WASHINGTON, DC 20036

Financials

$4.4M$4.1M2023$4.5M$4M2024
Revenue Expenses · by fiscal year end
Financials of NATIONAL BREAST CANCER COALITION FUND by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$4,513,144$4,005,885$507,259$7,053,036$421,758$6,631,278
December 31, 2023990$4,391,769$4,055,847$335,922$6,725,511$601,492$6,124,019
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$4,733,276
Program service revenue
$110,909
Investment income
$199,844
Net income from fundraising events
-$532,655
Other revenue
-$530,885

Expenses

Grants and similar amounts paid
$323,821
Compensation of officers, directors and key employees
$443,846
Other salaries and wages
$1,463,904
Salaries, compensation and benefits (total)
$2,207,970
Professional fundraising fees
$0
Legal fees
$612
Accounting fees
$33,600
Occupancy
$190,432
Travel
$60,782
Depreciation
$415
Program services (functional)
$3,451,427
Management and general (functional)
$221,662
Fundraising (functional)
$332,796

Balance sheet and other

Total assets, start of year
$6,725,511
Total assets, end of year
$7,053,036
Total liabilities, end of year
$421,758
Net assets, end of year
$6,631,278
Land, buildings and equipment
$20,451
Publicly traded securities
$4,240,173
Net assets without donor restrictions
$4,884,502
Net assets with donor restrictions
$1,746,776
Gross receipts
$5,165,214
Employees
16
Volunteers
14
Year formed
1991
State of legal domicile
PA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationFrom related orgsOther / benefits
FRANCES VISCOPRESIDENT
Trustee or director, Officer
46$221,154$28,846$23,700
MARA WALKERCHIEF PROGRAMS OFFICER
Officer
38$184,684$9,720$17,941
MELANIE WYNECHIEF POLICY OFFICER
Highest-paid employee
32$146,661$36,665$17,165
MICHELLE TREGEARCHIEF ADVANCEMENT OFFICER
Highest-paid employee
39$181,768$4,661$11,420
MARY DULANEYCHIEF OPERATING OFFICER
Highest-paid employee
38$166,968$8,788$17,138
NICOLE LEVINSCOMMUNICATIONS DIRECTOR
Highest-paid employee
38$150,922$7,943$16,438
MARGARET BUSHDIRECTOR, GRASSROOTS ENGAG
Highest-paid employee
37$114,266$9,265$5,558
ALEC CALLCHAIR
Trustee or director, Officer
1$0$0$0
MICHELE RAKOFFVICE CHAIR
Trustee or director, Officer
1$0$0$0
LINDA ROTHWEILERSECRETARY
Trustee or director, Officer
1$0$0$0
IRA HILLMANTREASURER
Trustee or director, Officer
1$0$0$0
SHERRY GOLDMANTRUSTEE
Trustee or director
1$0$0$0
JUDI HIRSHFIELD-BARTEKTRUSTEE
Trustee or director
1$0$0$0
DENNIS SLAMON MDTRUSTEE
Trustee or director
1$0$0$0
DOUGLAS WALLTRUSTEE
Trustee or director
1$0$0$0
5 more people on this return
NameTitleHours / weekCompensation
LIANE LINDNERTRUSTEE
Trustee or director
1$0
BRYAN JOHNSTRUSTEE
Trustee or director
1$0
ANN YAHNERTRUSTEE
Trustee or director
1$0
BETH EMERYTRUSTEE
Trustee or director
1$0
TODD NICKEYTRUSTEE
Trustee or director
1$0
990 for the year ended December 31, 2023: 21 people
NameTitleHours / weekCompensationFrom related orgsOther / benefits
FRANCES VISCOPRESIDENT
Trustee or director, Officer
46$221,154$28,846$23,700
MELANIE WYNECHIEF POLICY OFFICER
Highest-paid employee
32$146,200$36,550$16,417
MARY DULANEYCHIEF ADVANCEMENT OFFICER
Highest-paid employee
38$162,183$8,536$16,384
MARA WALKERCHIEF OPERATING OFFICER
Officer
38$160,980$8,473$16,574
MICHELLE TREGEARCHIEF PROGRAMS OFFICER
Highest-paid employee
39$172,586$4,425$6,993
ELIZABETH DELLSYARTEMIS PROJECT DIRECTOR
Highest-paid employee
40$149,565$0$15,419
MARGARET BUSHDIRECTOR, GRASSROOTS ENGAGEMENT
Highest-paid employee
37$110,936$8,995$5,623
ALEC CALLCHAIR
Trustee or director, Officer
1$0$0$0
LINDA ROTHWEILERVICE CHAIR
Trustee or director, Officer
1$0$0$0
CHRISTINE NORTONSECRETARY
Trustee or director, Officer
1$0$0$0
IRA HILLMANTREASURER
Trustee or director, Officer
1$0$0$0
SHERRY GOLDMANTRUSTEE
Trustee or director
1$0$0$0
JUDI HIRSHFIELD-BARTEKTRUSTEE
Trustee or director
1$0$0$0
DENNIS SLAMONTRUSTEE
Trustee or director
1$0$0$0
DOUGLAS WALLTRUSTEE
Trustee or director
1$0$0$0
LIANE LINDNERTRUSTEE
Trustee or director
1$0$0$0
BRYAN JOHNSTRUSTEE
Trustee or director
1$0$0$0
ANN YAHNERTRUSTEE
Trustee or director
1$0$0$0
MICHELE RAKOFFTRUSTEE
Trustee or director
1$0$0$0
BETH EMERYTRUSTEE
Trustee or director
1$0$0$0
TODD NICKEYTRUSTEE
Trustee or director
1$0$0$0

Address and contacts

Address (IRS master file)
2001 L ST NW STE 500 PMB 50111, WASHINGTON, DC 20036-4955
Principal officer (990 for 2024)
FRANCES M VISCO, 2001 L STREET NW 500, WASHINGTON, DC 20036
Signed the 990
FRANCES M VISCO, PRESIDENT
Phone
(202) 296-7477
Return prepared by
COUNCILOR BUCHANAN & MITCHELL PC

Mission

NBCC'S MISSION IS "TO END BREAST CANCER THROUGH THE POWER OF ACTION AND ADVOCACY." NBCC IS MADE UP OF ACTIVISTS WHO SET A PROGRAMMATIC AND RESEARCH AGENDA TO END BREAST CANCER AND USE THE POWER OF ACTION AND ADVOCACY TO FIGHT THE BREAST CANCER STATUS QUO, OVERCOME BARRIERS TO TRUE PROGRESS IN SAVING LIVES, AND EMPOWER AND TRAIN SURVIVORS AND ADVOCATES TO BE LEADERS FOR THIS CAUSE.

990 for the year ended December 31, 2024

Program accomplishments

  • EDUCATION AND TRAINING - THE CENTER FOR NBCC ADVOCACY TRAINING SUPPLIES THE EDUCATION, TOOLS, TRAINING, AND ACTION THAT ENABLE BREAST CANCER SURVIVORS AND OTHER ADVOCATES TO UNDERSTAND COMPLEX MEDICAL AND SCIENTIFIC INFORMATION AND TO TAKE LEADERSHIP ROLES IN CLINICAL, SCIENTIFIC, FUNDING, AND POLICY DECISION-MAKING THAT AFFECT BREAST CANCER.THE ADVOCATE LEADERSHIP SUMMIT IS A THREE-DAY EDUCATIONAL AND STRATEGY-BUILDING SESSION TO TRAIN AND EMPOWER BREAST CANCER SURVIVORS AND OTHER ADVOCATES BY PROVIDING INFORMATION AND BACKGROUND ABOUT BREAST CANCER AS WELL AS THE TOOLS AND TACTICS NECESSARY TO TAKE A LEADERSHIP ROLE IN BREAST CANCER ADVOCACY.PROJECT LEAD, NBCC'S INNOVATIVE SCIENCE TRAINING COURSE, IS DESIGNED TO HELP BREAST CANCER ACTIVISTS INFLUENCE RESEARCH AND PUBLIC POLICY. AN INTENSIVE TWO-TO-SIX-DAY PROGRAM, PROJECT LEAD PREPARES ADVOCATES FOR PARTICIPATION IN THE WIDE RANGE OF FORUMS WHERE BREAST CANCER RESEARCH DECISIONS ARE MADE. PROJECT LEAD INCLUDES:- PROJECT LEAD INSTITUTE: ANNUAL INTENSIVE SIX-DAY COURSE IN CORE SCIENCE TRAINING FOR ADVOCATE LEADERS TO LEARN THE LANGUAGE AND CONCEPTS OF SCIENCE WITH A FOCUS ON THE BIOLOGY OF BREAST CANCER, GENETICS, EPIDEMIOLOGY, RESEARCH DESIGN, AND ADVOCACY.- ADVANCED PROJECT LEAD: ONGOING EDUCATIONAL AND TRAINING SESSIONS FOR ADVOCATES WHO EXCEL IN SCIENCE AND HAVE SUCCESSFULLY COMPLETED PROJECT LEAD FOCUSING ON ENHANCING CRITICAL THINKING AND RESEARCH SKILLS.- CONTINUING EDUCATION FOR PROJECT LEAD GRADUATES: CONTINUED SCIENTIFIC EDUCATION AND RESEARCH INVOLVEMENT, INCLUDING LEADGRADS ONLINE RESOURCES, ADVANCED TOPICS SESSIONS AT VARIOUS SCIENTIFIC MEETINGS, AND LEADCASTS - ONLINE WEBINARS WITH WELL-KNOWN RESEARCHERS.- ONLINE CENTER FOR ADVOCACY TRAINING: NBCC'S ESTEEMED TRAINING EXPERIENCES BROUGHT DIRECTLY TO ADVOCATES IN A CONVENIENT AND UNDERSTANDABLE DIGITAL FORMAT.- TEAM LEADER TRAINING: PREPARES GRASSROOTS LEADERS TO UNDERSTAND THE LEGISLATIVE PROCESS AND TO FORWARD NBCC'S ANNUAL PUBLIC POLICY AGENDA.
    Expenses $1,464,701 · grants $12,821 · revenue $84,879
  • CATALYTIC RESEARCH PROJECTS AND COLLABORATIONS - NBCC'S ARTEMIS PROJECT IS CENTERED AROUND STRATEGIC SUMMITS, CATALYTIC WORKSHOPS, AND COLLABORATIVE EFFORTS WITH A MULTI- DISCIPLINARY AND DIVERSE GROUP OF STAKEHOLDERS. THIS ADVOCATE-LED, INNOVATIVE APPROACH ALLOWS SCIENTISTS, INDUSTRY REPRESENTATIVES, AND REGULATORS TO WORK COLLABORATIVELY WITH ADVOCATES TO DEVELOP AND IMPLEMENT STRATEGIC RESEARCH PLANS THAT COULD HAVE A SIGNIFICANT IMPACT ON PRIMARY PREVENTION AND SAVING LIVES. PROJECTS INCLUDE:- ARTEMIS PROJECT FOR A PREVENTIVE BREAST CANCER VACCINE: A STRATEGIC PLAN FOR THE DEVELOPMENT OF A PREVENTIVE IN BREAST CANCER.- ARTEMIS PROJECT ON THE PREVENTIVE OF METASTASIS: DETERMINING THE PROCESS BY WHICH BREAST CANCER SPREADS AND BECOMES LETHAL, AND HOW TO INTERVENE TO STOP IT. - SEED GRANTS FOR RESEARCH: NBCC HAS AWARDED SEED GRANTS TO ALLOW SCIENTISTS TO BEGIN THE RESEARCH REQUIRED IN KEY AREAS IDENTIFIED IN THE COLLABORATIVE RESEARCH PLANS.CLINICAL TRIALS INITIATIVE - NBCC WORKS WITH INDUSTRY AND THE RESEARCH COMMUNITY ON CLINICAL TRIALS THAT MEET THE CRITERIA OF NBCC'S CLINICAL TRIAL PROJECT. WE INVOLVE BREAST CANCER ACTIVISTS IN ALL ASPECTS OF CLINICAL TRIAL DESIGN, IMPLEMENTATION, AND OVERSIGHT. WE WORK TO IMPROVE ACCESS TO QUALITY CLINICAL TRIALS AND, THUS, TREATMENT AND CARE FOR WOMEN WITH BREAST CANCER AND STRATEGIES FOR THOSE AT RISK.
    Expenses $859,106
  • PUBLIC POLICY - PUBLIC POLICY PLAYS A SIGNIFICANT ROLE IN ALL ASPECTS OF BREAST CANCER. NBCC FOCUSES ITS PUBLIC POLICY ADVOCACY ON PRIORITIES THAT WILL HAVE A MAJOR IMPACT ON ENDING BREAST CANCER, INCLUDING THOSE THAT WILL INCREASE FUNDING FOR MEANINGFUL BREAST CANCER RESEARCH, PROVIDE ACCESS TO HIGH-QUALITY HEALTH CARE AND CLINICAL TRIALS, AND EXPAND THE INFLUENCE OF BREAST CANCER ADVOCATES EVERYWHERE BREAST CANCER DECISIONS ARE MADE.NBCC PROVIDES MEMBERS OF CONGRESS AND THEIR STAFF UP-TO-DATE INFORMATION ABOUT BREAST CANCER AND REPORTS ON RESEARCH DISCOVERIES THAT AFFECT POLICY AND APPROPRIATIONS. NBCC LEADERSHIP OFTEN TESTIFIES BEFORE CONGRESSIONAL COMMITTEES ON SUBSTANTIVE BREAST CANCER ISSUES.
    Expenses $489,194 · grants $311,000
  • PUBLIC INFORMATION, COMMUNICATIONS, AND OUTREACH - NBCC HAS UNDERTAKEN AN EXPANSIVE EFFORT TO CHANGE THE CONVERSATION AROUND BREAST CANCER TO A DIALOGUE ABOUT KNOWING HOW TO END THE DISEASE.- BREAST CANCER INFORMATION CAMPAIGNS: THE NBCC WEBSITE AND PRINT AND ELECTRONIC COMMUNICATIONS HELP EDUCATE THE PUBLIC WITH FACTS ABOUT BREAST CANCER. NBCC'S EXPERT STAFF ANALYZE RESEARCH STUDIES AND MEDIA COVERAGE AND PRESENT THE TRUTH BEHIND THE NEWS.- GLOBAL INFLUENCE: THE NBCC EXECUTIVE TEAM, BOARD OF DIRECTORS, AND ADVOCATE LEADERSHIP REPRESENT THE BREAST CANCER COMMUNITY, ADVOCATING ON ITS BEHALF AND SERVING ON SCIENTIFIC, MEDICAL, AND RESEARCH BODIES AT THE NATIONAL AND INTERNATIONAL LEVELS.THROUGH ALL OF THESE PROGRAMS, NBCC SUPPORTS AND FACILITATES THE RESEARCH NEEDED TO END BREAST CANCER, GLOBAL ACCESS TO THE NECESSARY INFORMATION AND LIFESAVING INTERVENTIONS, AND THE INFLUENCE OF LEADERS EVERYWHERE IN THE STRATEGIES TO END BREAST CANCER.
    Expenses $314,519
  • GRASSROOTS ADVOCACY FIELD NETWORK DEVELOPMENT AND SUPPORT - NBCC PROVIDES RESOURCES AND SUPPORT TO MEMBER ORGANIZATIONS NATIONWIDE AND ENHANCES EDUCATION AND TRAINING AMONG DIVERSE POPULATIONS OF BREAST CANCER ACTIVISTS.ALL ORGANIZATION AND INDIVIDUAL MEMBERS OF NBCC'S NATIONAL ACTION NETWORK RECEIVE EMAIL ALERTS THROUGHOUT THE YEAR, USUALLY TWICE EACH MONTH, WITH IMPORTANT INFORMATION AND TIMELY ACTIONS FOR THEIR ADVOCACY. NBCC ALSO CONVENES REGULAR CONFERENCE CALLS AND WEBINARS FOR THE GRASSROOTS FIELD NETWORK TO PROVIDE INDIVIDUALIZED GUIDANCE, INFORMATIONAL MATERIALS, AND PEER-TO-PEER SUPPORT.
    Expenses $297,929
  • OTHER PROGRAMS - THROUGH THE CLINICAL TRIALS INITIATIVE, NBCC WORKS WITH THE RESEARCH COMMUNITY TO INVOLVE BREAST CANCER ACTIVISTS IN ALL ASPECTS OF CLINICAL TRIAL DESIGN, IMPLEMENTATION AND OVERSIGHT AND INCREASE THE NUMBER OF HIGH QUALITY TRIALS CONDUCTED.
    Expenses $25,978 · revenue $27,800

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
52-1782065
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1993
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$7,053,036
Income (IRS master file)
$5,165,214

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$4,513,144$4,005,885$7,053,036XML
990December 2023$4,391,769$4,055,847$6,725,511XML
990December 2022$4,538,715$3,461,528$5,965,372IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-1782065).

Questions about NATIONAL BREAST CANCER COALITION FUND

What is the EIN of NATIONAL BREAST CANCER COALITION FUND?
The employer identification number (EIN) of NATIONAL BREAST CANCER COALITION FUND is 52-1782065.
Is NATIONAL BREAST CANCER COALITION FUND tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1993.
Are donations to NATIONAL BREAST CANCER COALITION FUND tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does NATIONAL BREAST CANCER COALITION FUND file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of NATIONAL BREAST CANCER COALITION FUND due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did NATIONAL BREAST CANCER COALITION FUND last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of NATIONAL BREAST CANCER COALITION FUND?
The 990 for the year ended December 31, 2024 names FRANCES M VISCO.
Who are the officers and directors of NATIONAL BREAST CANCER COALITION FUND?
The 990 for the year ended December 31, 2024 lists 20 people; 7 received compensation from the organization, the highest $221,154 (FRANCES VISCO, PRESIDENT).
How much revenue does NATIONAL BREAST CANCER COALITION FUND have?
On its 990 for the year ended December 31, 2024 it reported revenue of $4,513,144, expenses of $4,005,885 and total assets of $7,053,036 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia · Housing and shelter